Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

Saved in:
Bibliographic Details
Published inNature medicine Vol. 27; no. 10; pp. 1789 - 1796
Main Authors Dummer, R., Gyorki, D. E., Hyngstrom, J., Berger, A. C., Conry, R., Demidov, L., Sharma, A., Treichel, S. A., Radcliffe, H., Gorski, K. S., Anderson, A., Chan, E., Faries, M., Ross, M. I.
Format Journal Article
LanguageEnglish
Published 04.10.2021
Online AccessGet full text

Cover

More Information
ISSN:1078-8956
1546-170X
DOI:10.1038/s41591-021-01510-7